M. Tenet

发表

M. Tenet, 2020, Georgetown Medical Review.

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

Arun Ahuja, C. Rudin, J. Wolchok, 2018, Cancer cell.

Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers

Nikolaus Schultz, Charles M. Rudin, Matthew D. Hellmann, 2018, Clinical Cancer Research.

Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes.

D. Pe’er, M. Ladanyi, C. Rudin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Ash A. Alizadeh, Daniel K. Wells, C. Liu, 2020, Clinical Cancer Research.

Thrombotic complications of superficial endovenous ablation: a contemporary review of thermal and non-thermal techniques.

R. Dirks, Megan Tenet, S. Siada, 2021, The Journal of cardiovascular surgery.

Response and durability of anti-PD-(L)1 therapy in never- or light-smokers with non-small cell lung cancer (NSCLC) and high PD-L1 expression.

M. Mino‐Kenudson, A. Shaw, M. Hellmann, 2018 .

Thrombotic Complications After Radiofreqency and Cyanoacrylate Endovenous Ablation: Outcomes of a Multicenter Real-World Experience.

R. Dirks, S. Siada, Tyler Collins, 2022, Journal of Vascular Surgery: Venous and Lymphatic Disorders.

Racial Inequality in Medicine: How Did We Get Here?

M. Tenet, 2021, Georgetown Medical Review.